| scholarly article | Q13442814 |
| P50 | author | José M Seguí-Simarro | Q37840843 |
| P2093 | author name string | Pierre Coursaget | |
| Sandra Hervás-Stubbs | |||
| Alicia Fernández-San Millán | |||
| Patricia Corral-Martínez | |||
| Jon Veramendi | |||
| Julien Gaétan | |||
| Susana M Ortigosa | |||
| P2860 | cites work | Cost-effectiveness of a potential vaccine for human papillomavirus | Q33865463 |
| Plastid transformation in higher plants | Q35891630 | ||
| Expression of human papillomavirus type 16 L1 protein in transgenic tobacco plants. | Q51531420 | ||
| P433 | issue | 5 | |
| P921 | main subject | self-assembly | Q910150 |
| P304 | page(s) | 427-441 | |
| P577 | publication date | 2008-04-16 | |
| P1433 | published in | Plant Biotechnology Journal | Q15762398 |
| P1476 | title | Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic | |
| P478 | volume | 6 |
| Q48359222 | A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice. |
| Q50278167 | A synthetic gene increases TGFβ3 accumulation by 75-fold in tobacco chloroplasts enabling rapid purification and folding into a biologically active molecule |
| Q38285790 | Activation of human mast cells by retrocyclin and protegrin highlight their immunomodulatory and antimicrobial properties |
| Q59329445 | Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus |
| Q33737666 | Amyloid-like protein inclusions in tobacco transgenic plants |
| Q26747401 | Chloroplast genomes: diversity, evolution, and applications in genetic engineering |
| Q37859086 | Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. |
| Q37776719 | Chloroplasts as expression platforms for plant-produced vaccines |
| Q26748755 | Chloroplasts: state of research and practical applications of plastome sequencing |
| Q37834097 | Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies |
| Q37776721 | Development of plant-based mucosal vaccines against widespread infectious diseases. |
| Q38081965 | Developments in virus-like particle-based vaccines for HIV. |
| Q37951525 | Developments in virus-like particle-based vaccines for infectious diseases and cancer |
| Q30234320 | Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines? |
| Q42429984 | Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections |
| Q99711519 | Expression of LamB Vaccine Antigen in Wolffia globosa (Duck Weed) Against Fish Vibriosis |
| Q39118535 | Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts |
| Q34335370 | HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future |
| Q38992414 | Heterologous protein production in plant systems |
| Q57449904 | High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants |
| Q43129804 | High-level expression of a human β-site APP cleaving enzyme in transgenic tobacco chloroplasts and its immunogenicity in mice |
| Q51806657 | High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts. |
| Q37776720 | Human papillomavirus vaccines in plants |
| Q42278396 | Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras |
| Q37773267 | Immunotherapeutic polyoma and human papilloma virus-like particles |
| Q28083154 | Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models |
| Q84423777 | In planta production of a candidate vaccine against bovine papillomavirus type 1 |
| Q36504504 | Oral delivery of bioencapsulated exendin-4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta-TC6 cells |
| Q85177921 | Over-expression of peptide deformylase in chloroplasts confers actinonin resistance, but is not a suitable selective marker system for plastid transformation |
| Q55452687 | Physiological performance of transplastomic tobacco plants overexpressing aquaporin AQP1 in chloroplast membranes. |
| Q34687464 | Plant-based vaccines against viruses. |
| Q37983418 | Plant-derived vaccines: an approach for affordable vaccines against cervical cancer |
| Q36888029 | Plant-derived virus-like particles as vaccines |
| Q37776713 | Plant-made immunogens and effective delivery strategies |
| Q26783111 | Plant-made oral vaccines against human infectious diseases-Are we there yet? |
| Q37616370 | Plant-made vaccine antigens and biopharmaceuticals |
| Q30386732 | Plant-made vaccines for humans and animals. |
| Q57247534 | Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes |
| Q26774629 | Plastids: The Green Frontiers for Vaccine Production |
| Q37488845 | Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer |
| Q36102960 | Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves |
| Q33890189 | Social values and scientific evidence: the case of the HPV vaccines |
| Q36327788 | Stable plastid transformation for high-level recombinant protein expression: promises and challenges. |
| Q84970027 | Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain |
| Q91688100 | Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity |
| Q39081725 | Synthetic plant virology for nanobiotechnology and nanomedicine |
| Q58917291 | Temporal and spatial distribution of erythropoietin in transgenic tobacco plants |
| Q26781748 | The Engineered Chloroplast Genome Just Got Smarter |
| Q37393964 | The green vaccine: A global strategy to combat infectious and autoimmune diseases |
| Q38424974 | The potential of plants for the production and delivery of human papillomavirus vaccines |
| Q43587719 | The vaccine adjuvant extra domain A from fibronectin retains its proinflammatory properties when expressed in tobacco chloroplasts |
| Q58477212 | Tobacco plastidial thioredoxins as modulators of recombinant protein production in transgenic chloroplasts |
| Q45359462 | Transient expression of Human papillomavirus type 16 L2 epitope fused to N- and C-terminus of coat protein of Potato virus X in plants |
| Q53476367 | Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco. |
| Q54080674 | Transplastomic expression of a modified human papillomavirus L1 protein leading to the assembly of capsomeres in tobacco: a step towards cost-effective second-generation vaccines. |
| Q38152475 | VLPs and particle strategies for cancer vaccines |
| Q33870122 | Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases |
| Q38081975 | Virus-like particles produced in plants as potential vaccines |
Search more.